While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

Here are four use cases that best exemplify those already-established impacts of AI on drug discovery: 1. Target identification and mechanism-of-action (MOA) delivery [1] [2] ...

We think that most patients can get to 4 drugs in 4 weeks. It’s a catchy phrase, but it’s a nice way of framing the goal. There are several reasons for this approach.

Parallel Bio, a biotech company unlocking the human body’s own power to cure disease, today unveiled $4.3 million in seed funding. The investment capi ...

Drug discovery is extraordinarily difficult. “In 100 years or so of contemporary medicine, we’ve found treatments for only around 500 of the roughly 7,000 rare diseases,” says David Pardoe ...